At-a-glance
As healthcare innovation accelerates, fragmentation has the potential to intensify — widening existing gaps and forming new barriers. Discover how the landscape is shifting and what is needed to bridge the gaps between patients, prescribers, payers and pharmacies. Get an overview of key insights below, then request a full report for deeper analysis and data.
Rising costs, complex therapies and regulatory reforms heighten the urgency for patients seeking access to medications. Integrated solutions designed to close adherence gaps and improve patient outcomes are more essential — and more achievable — than ever before.
of patients surveyed experienced some kind of delay in accessing their medication.[0]CoverMyMeds Patient Survey 2023.
of providers agree that claim denials are increasing.[0]Nguyen, Kelly. “Healthcare Claim Denial Statistics: State of Claims Report 2024.” Healthcare Blog, 7 Oct. 2024.
of physicians say that the prior authorization process delays necessary patient care.[0]American Medical Association. “Health Insurance Denials, Delayed Care and Medication Access: How Prior Authorization Hurts Patients.” American Medical Association, 15 July 2024.
of pharmaceutical decision makers plan to increase their spending on access in the next five years.[0]Dinesh Kabaleeswaran, Jennifer Klarer, May 1, 2024, Asembia Specialty Pharmacy Summit, From Pipeline to Patient: Understanding Barriers to Access in 2024 and Beyond.
Every day, patients face barriers to accessing the medications they need to live healthier lives. The 2025 Medication Access Report: Barriers to Bridges challenges us to think differently, work together and build a healthcare future that is more connected, compassionate and accessible for all.
Download our most recent report on the barriers to medication access and explore this year's key insights.
— Kevin Kettler, President, CoverMyMeds
Rethinking the outdated, linear patient journey helps unlock more comprehensive access strategies — turning today's challenges into opportunities for better patient outcomes.
Patients face unique and evolving challenges across access, affordability and adherence. These factors are deeply interconnected, requiring multidimensional solutions tailored to individual needs.
Specialty pharmacies have become critical to the prior auth and insurance processes, demanding more data-driven, automated solutions to provide personalized support, streamline care coordination and improve outcomes for patients with complex health conditions.
is the estimated value of the specialty drug market.[0]Josh Nelson, Megan Preiner, Joan Thompson, and Ben Stern. “Navigating the Complexities of the Specialty Drug Market.” THL, 17 May 2024.
In 2023, the specialty pharmaceutical market was valued at around $68.3 billion and is expected to reach approximately $1,532.8 billion by 2033.
of drug launches are expected to be specialty[0]PharmD, Andy Szczotka. “Navigating the Rapid Growth of Specialty Drugs: Opportunities, Challenges, and the Path Ahead.” Pharmacy Times, 30 Aug. 2024.
of total drug spend is on specialty drugs[0]Josh Nelson, Megan Preiner, Joan Thompson, and Ben Stern. “Navigating the Complexities of the Specialty Drug Market.” THL, 17 May 2024.
“Medication is the most powerful tool we have to keep our patients out of the hospital.”
patient support programs
Patient support programs help people access, afford, and adhere to their prescribed medications. Yet too many patients don’t know these programs exist, or they struggle to navigate the process.
Step beyond traditional solutions and explore the potential of dimensionalized access strategies. Join industry leaders shaping the future of healthcare — fill out the form to get the full 2025 Medication Access Report delivered straight to your inbox.